Rentschler Biopharma: A 50-year Legacy of Exceptional CDMO Expertise
Explore how Rentschler Biopharma duels biopharmaceutical innovation, spanning from pioneering biological products to cutting-edge cell and gene therapies
Benedikt von Braunmühl (CEO) and Federico Pollano (vice president of business development) at Rentschler Biopharma explain what sets their CDMO apart. Viewers will learn about:
- What exceptional CDMO expertise means: 25% of all FDA approved biopharmaceuticals in 2023 were supported by the company
- Rentschler Biopharma’s US offerings, as well as commercial and development expertise
- How the company is leveraging its expertise in the field of gene therapy
Investigating the Pharmaceutical Ingredients Industry with Myrna Wilson (DCAT Week 2023)
May 26th 2023Myrna Wilson, director, Global Marketing, Strategic Growth and Technical Sales, Pharmaceutical Ingredients, Univar Solutions, discusses the state of the biopharma supply chain, movements in the patent industry, and more.
Investigating Inhalation Forms and Drug Delivery with Shabbir Mostafa (DCAT Week)
May 19th 2023Shabbir Mostafa, head of Business Development — Advanced Delivery Systems, Recipharm, sat down with Grant Playter, associate editor, during DCAT week to discuss the current state of inhalations forms and drug delivery.
